Interview: Karel Kucera – CEO, CzechInvest, Czech Republic

17.06.2016
Charles Kucera, CEO, Czech InvestThe CEO of CzechInvest elaborates on the significance of the healthcare and life science industry for the Czech Republic’s transition into an industry 4.0. Furthermore, he reviews what the Czech Republic has to offer for foreign investors over its regional neighbors. Before assuming the position of CEO at CzechInvest you have worked in numerous industries. How does this diverse background give you and your work at CzechInvest a competitive edge?
The Czechs are naturally good at developing new technology and solutions needed on a global scale
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In
Tags:
Pharma, Pharmaceuticals, Healthcare, FDI, Czech, Czech Republic, Industry 4.0, Investment, Transition, Central Europe, Gilead, MSD, Interview, Insight, Exclusive, Executive, Free

Related Interviews

Jiří Pavlíček – CEO, Aspironix & Chairman, CzechMed and Miroslav…

Miroslav Palát, president of CzechMed, the medical device association in the Czech Republic, and Jiří Pavlíček, who combines the responsibility of Chairman of the association and CEO of the medtech…

Roman Samiec – General Manager, Thuasne Czech Republic

Roman Samiec, general manager of Thuasne Czech Republic, introduces the company as a key competitor in the medical devices field, with their niche products addressing the unmet medical need in…

Roman Grunt – CEO, Quinta Analytica, Czech Republic

Roman Grunt, CEO of Quinta Analytica, gives us an overview of the activities of how the Czech firm has managed to attract customers across the country and beyond by positioning…

Related Articles

Australia / Artificial Intelligence Can Save Pharmacovigilance

Writing in the January edition of DIA’s Global Forum magazine, Julia Chan, David Liew, Jana Stojanova, and Chris McMaster of Austin Health, Melbourne and St. Vincent’s Hospital Sydney outline how…

China / Emerging Pharmacovigilance Framework Ensuring Safe COVID-19 Vaccines

PPC China’s Sophia Duan, writing in the January edition of DIA’s Global Forum magazine, details how the emergence of an effective pharmacovigilance ecosystem is helping to safeguard the rollout of…

Spain / 5 Key Industry Trends 2021

According to recent IQVIA and industry association reports, the Spanish pharma market, valued at EUR 21.6 billion per year, continues to grow at a relatively slow pace. Other key trends…

Latest Report

Denmark Pharma Report 2021

Related Content

Pharma
Pharmaceuticals
Healthcare
FDI
Czech
Czech Republic
Industry 4.0